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Abstract
Patients with congestive heart failure (CHF) are at increased risk for hospital readmission
within 30 days of discharge. The gap in practice involves the coordination of care for
patients with CHF in the transition from hospital to home. Patients with CHF are at
increased risk for hospital readmission due to barriers involving self-care,
communication, and coordination of care. The purpose of this project was to implement a
clinical practice guideline (CPG) that used a predictive tool and clinical pathway for
coordination of care for CHF patients at increased risk for hospital readmission within 30
days. The DNP project involved using the chronic care model as a framework and
addressed the practice-focused question, which asked whether the CPG would be
accepted by an expert panel for full implementation. The CPG was presented to a 9member expert panel, all members of a larger QI readmission task force. There were 5
cardiac providers, and 4 nursing or administrative leaders with decision-making abilities
at the site. Scores on the Agree II instrument from nine experts ranged from 5.5 to 6.81
across 23 items and 6 domains indicating overall agreement on the CPG.
Recommendations of the panel included a change to the clinical practice guideline to
reflect ischemic workup and criteria for admission when a patient presents to the
emergency department. The expert panel agreed to full implementation of the CPG. The
impact of this CPG will lead to decreased needs for hospital readmission, improved
coordination of care, improved communication between the patient and the healthcare
team, and empowerment of patients, leading to positive social change in terms of caring
for patients with chronic CHF.
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Section 1: Nature of the Project
Introduction
Heart failure is a significant cause of morbidity and mortality and is one of the
leading causes of hospital admission and readmission. These readmissions affect more
than a million patients annually, and anticipated healthcare spending is expected to
eclipse $69.7 billion in 2030 (Zohrabian, Kapp, & Simoes, 2018). The Centers for
Medicare and Medicaid Services (CMS) began reviewing heart failure readmission rates
in 2012 and implemented penalties to hospitals with increased 30-day all-cause
readmissions (CMS, 2019). Although there have been advances in the reduction of
unnecessary hospital readmissions, many of these readmissions may be avoided when
guideline-directed therapies are implemented in a timely, practical, or patient-centered
manner (Gordin & Fonarow, 2016; Greene et al., 2018). Working to improve quality of
life for patients with chronic illness begins with understanding what influences contribute
to hospital admission and readmission. Each hospital readmission places the patient at
increased risk for complications such as hospital-acquired illnesses and stress, while also
placing additional financial burdens on patients (Fingar & Washington, 2015). The
application of clinical guidelines allows for improving the patient experience while
optimizing care. Creating treatment plans that incorporate current evidence into daily
practice enables practitioners to develop individualized treatment plans while improving
the lives of patients.
The financial burden of hospital readmission for heart failure exacerbates after 30
days of discharge. Healthcare teams have been challenged to identify the etiology of
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readmission, develop methods to predict heart failure readmission, and evaluate strategies
to prevent unnecessary readmission (Kitsiou, Paré, & Jaana, 2015). To decrease
unnecessary hospital readmission and improve quality of life for patients with congestive
heart failure (CHF), the DNP clinical practice guideline (CPG) incorporates evidencebased practice into recommendations of care for patients with CHF, through coordination
of care from the acute care setting to the ambulatory setting. This process is intended to
decrease heart failure readmission by optimizing patient care and overcoming barriers
that lead to unnecessary hospital readmission (Fischer et al., 2016).
To further understand the need for hospital admission or risk for readmission in
CHF patients, it is imperative to determine the barriers that these patients face. These
readmissions are often multifactorial and related to a lack of appropriate discharge
planning, patient education, communication, and transition of care planning (Wood,
Migliore, Nasshan, Mirghani, & Contasti, 2019). Because of the multidisciplinary nature
of inpatient hospital care, gaps in practice can result in readmission. If patients are not
prepared at the time of discharge with adequate resources to bridge the transition from the
inpatient setting to the next setting (home, long-term care, or subacute rehabilitation), the
risk for readmissions increases. Programmatic changes have been developed as solutions.
National initiatives detailed by CMS, have provided a foundation for creating processes
focused on medication management, discharge planning, close follow up after discharge,
and ongoing performance monitoring (Milfred-LaForest et al., 2017). Thus, the DNP
project will involve using these existing strategies to construct a CPG for presentation to
an expert panel for approval and implementation. Preventing readmission can improve
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quality of life for patients as well as reduce the overall cost of caring for these patients,
contributing to positive social change.
Problem Statement
Healthcare systems have been experiencing increased readmission rates for
patients with CHF, with a projected increase in the future due to the number of patients
affected by this chronic illness. Readmission rates for 2018 in patients with heart failure
are higher than the national average of 21.7%, at one of five acute care hospitals within
the network. Current readmission rates are 21.78%, which is 4-6% higher than the other
four facilities in the system. Although the current 30-day readmission rate is at pace with
the national average, it still results in penalties to revenue for the organization and costs
to patients. The consequences to patients and the organization are both substantial. The
cost of care for each of these readmissions is approximately $10,100 to $14,200 and may
vary depending on the patient’s insurance (Bailey, Weiss, Barrett, & Jiang, 2019). There
were 326 patients identified as readmitted within 30-days of discharge in this 1-year
period of time. Of these patients, more than half were discharged to home or self-care
following their admission. In addition, patients transferred to home with home care and
transitioned to long-term care were also included in the 1-year sample. Reducing hospital
readmission aligns with practice site goals and healthcare initiatives, affects healthcare
and healthcare systems financially, and positively impacts lives of patients and their
families. Patients may find it challenging to understand their medical diagnosis due to
complexity, lack of social support, or difficulty maneuvering through the healthcare
system. Negative impacts due to this may increase the risk of hospital readmission.
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Factors that negatively affect patients following hospital admission or
readmission are often related to lifestyle modification. In addition to dietary and
medication compliance, patients with CHF may experience complications due to
decompensation of their illness during hospital admission. Morrison, Palumbo, and
Rambur (2016) said that CHF patients are at increased vulnerability within the first
weeks from discharge. Home visits occurred within the first 24 to 48 hours postdischarge, with the implementation of interventions applicable to reduce short-term and
long-term hospital readmission. Initial assessments included a comprehensive physical
examination, medication reconciliation, and patient education involving self-management
of the disease. In addition, transitional care focused on the evaluation of additional needs
related to home care, transportation, and nutritional needs (Morrison, Palumbo, &
Rambur, 2016). Helping patients understand the importance of self-care, lifestyle
modifications, and overcoming potential barriers will improve quality of life for these
patients and their families.
Purpose Statement
The need to reduce hospital readmission in patients with CHF represents a gap in
practice. Even with the use of predictive models, transitional care clinics, and close
follow up, readmission rates remain elevated beyond the national average. There may be
barriers to self-care that patients experience, such as lack of transportation, insufficient
financial means for medication, or deficient dietary regimens; organizational processes
do not address these barriers. Current processes do not anticipate patient questions that
occur after discharge regarding daily management or changes that occur in patients’
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current health status. There are communication deficits in terms of the transition of care
that exist between the hospitalist, case manager, discharging nurse, and social services
following discharge.
These gaps in practice identified are related to transition of care for patients with
CHF from hospital to home. The purpose of the DNP project was to develop and
implement a CPG using a risk stratification tool, evidence-based practice guidelines for
CHF, heart failure order sets, and transitional care services designed specifically for
patients with CHF. Hospital readmission rates currently exceeding the national average
may not be reflective of the care provided. Thus, the practice-focused question that will
help to close the gap in practice is: Will a transition of care practice guideline be accepted
for full implementation by an expert panel at this site as a strategy to reduce this 30-day
readmission rate in CHF patients??
A transitional care clinic was implemented in May 2019 to assist with the
transition from hospital to home. In the initial evaluation of the use of the post-discharge
clinic in October 2019, more than 130 patients had been admitted with CHF, and only
two patients had participated in the use of the transitional care clinic, representing an
additional gap in transitional services. Barriers preventing self-care at home included lack
of transportation to the clinic, lack of knowledge of appointment at the time of discharge,
and inconsistent discharge instructions. Patients could benefit from the use of visiting
nursing services post-discharge; however, these services may not be fully taken
advantage of due to lack of referral or evaluation for eligibility for patients.
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A CPG incorporates the use of patient education, communication, and transitional
care development to assist in the coordination of care from acute care to ambulatory
settings. Each member of the healthcare team must work to effectively transition patients
to the home setting while decreasing their risk for readmission. Donaho et al. (2015)
noted that involving the care team during hospital admission improves communication
while creating the expectation of continuity of care. The practice guideline project allows
for the creation of a comprehensive care approach to assist patients in the transition to
home and will close the current gap in practice at the site.
Nature of the Doctoral Project
Multiple factors may influence hospital readmission. Ryan, Bierle, and Vuckovic
(2019) noted that the transition of care should be individualized and multifaceted due to
the complexity of CHF patients. The DNP project involved the development of a CPG
intended to improve patients’ health by providing therapies based on clinical evidence.
The development of a CPG involved the use of multidisciplinary teams following a
comprehensive review of the evidence. The use of a CPG empowered staff to facilitate
shared decision making, identify gaps in practice, and overcome barriers to care.
Hospital readmission is attributed to the discharge process as patients transition
from hospital to home, which involves access to care, inconsistencies in discharge
instructions, and insufficient education in the self-management of the disease process.
Current processes allow for initial risk stratification of patients with chronic diseases;
however, outcomes of this risk stratification are unclear. Using a risk stratification model,
the LACE index tool demonstrates a score based on the hospital length of stay (L), acuity
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of admission (A), comorbidities (C), and emergency department visits (E). This score
provides objective criteria for the prediction of hospital readmission (Miller, Nguyen,
Vangala, & Dowling, 2018). The current use of the LACE index tool at the practice site
is unclear; however, through the CPG, the transition of care process will actively include
the use of this predictive score.
As part of the transition of care, the OPTIMIZE-HF and Get with the GuidelinesHeart Failure (GWTG-HF) demonstrated a reduction in 30-day readmission rates when
CHF patients were evaluated within 7 days from discharge (Blood, Fraiche, & Eapen,
2017). In addition to follow up within 7 days from discharge, designated transitional care
paperwork should include the medical diagnosis, current medication regimen, diagnostic,
and pending workup. Alternative strategies, such as telemonitoring of patients with heart
failure, providing diagnostic evidence of fluid changes resulting in changes in pulmonary
pressures or thoracic impedance may be necessary in the days to weeks preceding
exacerbation of symptoms (Murphy, Shanks, & Alderman, 2019). Coordination of care
when transitioning patients to home, use of telemonitoring, and close followup allows for
early intervention and adjustments in treatment plans. Implementation of the CPG
supported by evidence-based practice allows for transitional care from hospital to home
and facilitates communication between patients and their healthcare team. The objective
of this CPG was to decrease hospital readmission and improve self-care of patients with
CHF.
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Significance
This project is intended to have a positive impact on primary stakeholders,
including patients, families, organizations, healthcare providers, nursing administration,
and quality improvement teams. Secondary stakeholders of the DNP project include
interdisciplinary teams comprised of acute care team members from case management,
acute care cardiac rehabilitation, nursing, hospitalist teams, cardiologists and cardiology
advanced practice providers (APPs), and pharmacy staff.
In addition to these teams, ambulatory stakeholders included ambulatory staff
(i.e., transitional care nursing, ambulatory cardiac rehab, ambulatory case management,
and ambulatory nursing staff). These teams improve the lives of CHF patients when
engaged in a CPG that bridges gaps in practice. This guideline focuses on optimizing
medical therapies and transitioning care, while overcoming barriers to care for this
patient population to decrease the risk for unnecessary hospital readmissions.
Summary
Patients with CHF are at increased risk for hospital admission and readmission.
This disease affects more than 6.5 million individuals in the United States, leading to
annual healthcare expenditures of more than $39 billion (Donaho et al., 2015). Much of
this cost is related to unnecessary hospital readmission for patients with a primary or
secondary diagnosis of CHF. Healthcare teams play a role in reducing these hospital
readmissions through the ongoing management of patients. The gap in practice identified
inconsistencies in transitional care leading to hospital readmission. The purpose of the
DNP project was to bridge the gap in practice through a CPG that will more accurately
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define the transition of care process for CHF patients at the site. This guideline has the
potential to prevent or reduce 30-day hospital readmissions, improving patients’ quality
of life, and reducing costs of care. Section 2 will provide a link to concepts, models, and
theories, as well as relevance of nursing practice from the published literature to provide
support for the CPG.
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Section 2: Background and Context
Introduction
Heart failure is a significant cause of morbidity and mortality, and one of the
leading causes of hospital admission and readmission. These readmissions affect more
than a million patients annually, accounting for more than $1.7 billion in healthcare
spending (Mirkin, Enomoto, Caputo, & Hollenbeak, 2017). Noting the magnitude of this
issue, CMS began reviewing heart failure readmission rates and implemented penalties to
hospitals with increased 30-day all-cause readmissions, creating the foundation for the
Hospital Readmission Reduction Program (HRRP) (CMS, 2019). While there have been
advances in the reduction of unnecessary hospital readmissions, many of these
readmissions may be avoided when guideline-directed therapies are implemented in a
timely, practical, or patient-centered manner (Ryan, Bierle, & Vuckovic, 2019). Working
to improve quality of life for patients with chronic illnesses begins with understanding
influences that contribute to hospital admission and readmission.
The practice focus question addressed was: Will a transition of care practice
guideline be accepted for full implementation by an expert panel at this site as a strategy
to reduce this 30-day readmission rate in CHF patients? The gap in practice involves
readmission rates, which at this practice site remain elevated beyond the national average
of 21.7%. The purpose of the DNP project is to bridge the gap in practice through a
practice guideline that will more accurately define the transition of care process for CHF
patients.
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Concepts, Models, and Theories
CHF is a chronic disease requiring ongoing daily management that leads to an
increased risk for hospital readmission. With the establishment of the HRRP by the CMS
in 2012, hospitals may be penalized with reduced payments with increased 30-day
readmission rates. Due to this initiative, healthcare systems have been evaluating
methods to identify patients who may be at risk and implementing interventions that
potentially reduce the need for hospital readmission in patients with CHF. Reduction of
risks for hospital readmission requires a multifaceted approach. This CPG involves using
predictive risk models to risk-stratify patients, identify patient and system barriers, and
identify methods to overcome these barriers.
Predicting Risk of Readmission
Flanagan et al. (2018) conducted a retrospective medical record review to
evaluate factors that lead to hospital readmission. Identification of individual behaviors,
such as social support needs assessment. These health behaviors influenced the likelihood
of hospital readmission. It was also noted that patients with chronic CHF compared to a
new onset diagnosis are 2.5 times increase the risk for readmission. Additional
assessments of these patients, using risk assessment tools such as the Braden skin score,
showed that patients with increased Braden scores are at 20 times increased risk for
readmission. Thus, demonstrating the need for comprehensive risk assessment prior to
discharge from the acute care setting (Flanagan et al., 2018).
Ritt and Taylor (2016) conducted a descriptive non-experimental study,
implemented in the electronic health record (EHR) to validate the use of the LACE index
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tool in predicting hospital readmission in patients with CHF. This LACE index score
demonstrates objective data demonstrating the potential risk for hospital readmission.
Implemented at hospital admission, it allows for identification of patients who are at
moderate to high risk for readmission. Patients with elevated scores demonstrate not only
potential risks for hospital readmission but an increased risk of early death after discharge
from the acute care facility.
Mirkin, Enomoto, Caputo, and Hollenbeak (2017) used administrative discharge
data, detailed patient variables: including age, gender, and race, as well as diagnosis and
procedure codes to determine risk for readmission. Additional characteristics of CHF
patients that demonstrated that increased the risk for readmission included those who
were readmitted from home, less than 65 years in age, black race/ethnicity, have an
increased length of stay, demonstrate an emergent admission, and have an increased
comorbidity burden. Factors that may influence readmission include sociodemographic
discriminators of male sex, age, black race, and Medicare insurance is associated with
increased risk for readmission
Miller et al. (2018) evaluated the use of a 3-question survey compared to the
LACE index tool to assess provider ability to predict a patient’s risk for readmission.
Both the LACE index and the provider's assessment demonstrated predictive values in
determining the potential for readmission; however, the LACE showed predictive value
for new medical residents or inexperienced clinicians. Neither the survey or the LACE
index identifies the patient's understanding of their disease process or provides evidence
related to adherence to a medication regimen or plan of treatment.
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In addition to the LACE index, the use of predictive models such as the
HOSPITAL predictive score may provide insight into the risk of unnecessary hospital
readmission. Aubert et al.’s (2017) retrospective study evaluated the prognostic value of
the simplified HOSPITAL score for predicting 30-day hospital readmission. This
predictive model involves using seven clinical variables a discharge: hemoglobin levels,
cancer diagnosis, sodium levels, nonelective admission, number of admissions in the past
12 months, and hospital length of stay. This model allows for the prediction of avoidable
hospital readmission, and this score may be calculated prior to hospital discharge. While
this demonstrated a predictive model of CHF patients at increased risk, there is limited
evidence regarding interventions for this at-risk population.
Predictive models may also assist with the identification of patients at risk, as
patients with CHF may benefit from palliative care. Fasolino and Phillips’ (2016)
retrospective analysis used the risk readmission assessment tool (RRAT) and the need for
palliative care in this patient population. The use of this tool allows for incorporating
nonhospice palliative care (NPHC) to improve quality of life for CHF patients and their
families. NPHC provides for a multidisciplinary approach to care, addressing physical,
emotional, and spiritual needs of patients. The use of NPHC aids in symptom
management of this at-risk population, while establishing goals for end-stage heart failure
patients and assisting with enrollment into hospice if and when appropriate.
The use of predictive models allows for identification of patients that may be at
increased risk for readmission. While these risk stratification tools demonstrate predictive
risk, used alone is not enough to identify a patient’s risk for hospital readmission.
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Predictive models, such as the LACE index tool, incorporate comorbid conditions that
may increase the patient’s risk for hospital readmission. Limitations of this tool include
age of the patient, gender, demographics such as socioeconomic status, and ethnicity.
While these limitations play a role in the patient’s condition, they influence the outcome
of predictive score.
Transitional Care Model
Koser, Ball, Homa, and Mehta (2018) conducted a retrospective chart review
aimed at the development of an ambulatory heart failure clinic to reduce hospital
readmission. Patients with a primary or secondary diagnosis of CHF were admitted to this
clinic. The initial visit included detailed evaluation, monitoring at designated intervals,
access to care, and aggressive management of symptoms in the ambulatory setting.
Implementation at this clinic included an interdisciplinary team that evaluated patients
prior to discharge to assess barriers to adherence to treatment regimens and
acknowledgment of follow up appointments. At the first ambulatory appointment,
patients were provided with tools such as a blood pressure cuff and scale to ensure that
they were able to follow their blood pressure and weights accurately. In addition, the
nursing staff contacted the patient weekly by phone for 60-days post-discharge.
Hudali, Robinson, and Bhattarai (2017) discussed efforts to reduce hospital
readmission and costs associated with this readmission through the use of a transitional
care clinic facilitated by a hospitalist care team. Statistical significance was demonstrated
by the use of a post-discharge clinic, noting a reduction from 11.7% to 3.8%. Facilitation
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of this clinic allows for early intervention post-discharge, assisting patients with
educational needs, and reviewing medications.
The use of transitional care models allows for the translation of evidence into
practice and improving patient outcomes. Interventions include close follow up, use of
multidisciplinary teams, and coordination of care lower the patient’s risk for hospital
readmission. Implementation of a CPG allows for continuity of care across disciplines,
increases efficiency, optimizes care, ultimately decreases the need for hospital
readmission.
Barriers to Care
Ahmad et al. (2019) conducted a qualitative study to evaluate experiences and
perceptions of patients with congestive heart failure, their caregivers, and the healthcare
team. Using a free listing approach, respondents were asked open ended questions, then
asked to provide a list of words related to the prompt and provide an order of importance
of these items. The results were then triangulated between the patient, caregiver, and the
healthcare team to create a better understanding of reasons for hospital readmission.
This study allowed for identification of target areas for further interventions to reduce the
need for hospital readmission. Key areas identified were related to patient
teaching/education, barriers and priorities for self-care, adherence to therapeutic
regimens, communication and management of symptom burden. Barriers identified by
healthcare providers included assessment of management related to functional status,
ability to perform activities of daily living, and individual personal influences on care
processes. In response to hospital readmission, the patients, caregivers, and healthcare
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teams identified areas of improvement related to self-care, management of symptoms,
action plans when symptoms change, and patient perception of the need for hospital
readmission.
Trivedi et al.’s (2019) qualitative study examined barriers to self-care and
management of CHF. Key points that emerged included fragmented or poorly
coordinated care, concern for organizational barriers to care, barriers to collaborative
practice, sources of conflict, and successful strategies to overcome barriers. CHF patients
and healthcare providers noted the key concept of lack of knowledge in self-care as
detrimental to the patient’s health status. Common themes were further identified based
on a coding system that clarified barriers to self-care and the strategies to overcome these
barriers. The patient identified barriers included lack of knowledge in self-care, lack of
information materials, disempowerment related to symptom management, and ineffective
communication between patient, primary caregiver, and healthcare team. Healthcare
provider identified barriers included lack of standardized protocols, lack of knowledge
with medication use and purpose, the concern that current care practices do not align with
guideline care, communication with patient at time of discharge, coordination of care at
discharge, and provider to provider communication. Limitations noted by Trivedi et al.
(2019) that all CHF patients in the study were male. It was also noted race concordance
between patient and provider aligned with adherence to the treatment plan.
Ryan, Bierle, and Vuckovic (2019) summarized existing data from multiple
registries that have identified preventable or unpreventable hospital readmissions and
discussed a focus on treatment strategies to reduce hospital readmission. One intervention
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is not sufficient to address the complexity of CHF patients; the transition of care should
be multidisciplinary with a focus on the discharge process. Discharge planning should
include self-management of the disease process, patient education, evaluation of
biomarkers, identification of comorbidities, assessment of the patient’s perception of the
quality of life, and depression screening. Overcoming obstacles that may interfere with
transition of care have been identified into common themes, demonstrating a
multidisciplinary approach to post-hospital care.
Identification of barriers to care allows practitioners to assess the needs of the
patients and their families. These barriers may highlight inefficiencies in quality of care,
use of guideline-directed therapy, and optimal medical management of patients with
CHF. Lack of evidence-based care may not be reflective of the quality of care; however,
it leads to ineffective transitioning, placing the patient at risk for unnecessary hospital
readmission.
Palliative Care
Hupcey, Kitko, and Alonso (2016) conducted a longitudinal study to evaluate the
patient’s perceptions of the severity and terminality with advanced heart failure. These
patients had a predicted survival rate of fewer than two years. The sample size included
100 patients with advanced heart failure, with 40% of these patients with a less than one
year expected rate of survival (Hupcey, Kitko, & Alonso, 2016). Using a patient-centered
approach, the healthcare team implemented a multidisciplinary approach that included
the use of palliative care. The use of palliative care with this patient population allows for
initiation of resources that include goal setting and ways to improve the patient’s quality
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of life. Survival rate of the patients included in the study was less than 2 years. Majority
of patients included did not perceive heart failure to be a terminal disease process. This
perception affected the incorporation of palliative care into the care process for these
patients.
Diop et al. (2017) noted the complexity of patients with CHF and the use of a
multidisciplinary approach allows for incorporating care that impacts the patient
physically, cognitively, and socially. To provide patient-centered care, the management
of these patients requires individualized care-planning, communication, and the use of
palliative care. This systematic review assessed the effectiveness of palliative care and
interventions for heart failure patients (Sidebottom et al., 2015; Wiskar et al., 2017). It
was noted that as this patient population continues to progress toward advanced disease
processes, the implementation of palliative care is imperative. Interventions that
incorporate self-care, team-based palliative care along with heart failure management,
improve patient outcomes as well as decrease health care costs and the utilization of
resources, needed by hospital readmission (Chuang et al., 2016).
Chronic Care Model
The chronic care model provides a framework in the management of patients with
chronic illness. Ballo et al. (2018) evaluated the use of this framework through a cohort
study to determine the prognostic impact in chronically ill patients. Patients identified for
were evaluated by a general practitioner at routine intervals, received counseling
regarding lifestyle modifications, placed on guideline-directed medication therapies, and
placed on a clinical pathway based on their diagnosis. Limitations included the lack of
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referral to specialty care, including cardiology and the input of appropriate diagnosis
coding for congestive heart failure. There is prognostic support in the use of the chronic
care framework, demonstrating a decrease in mortality, but an increase in hospitalization.
Implementation of the chronic care model in the CPG allowed for ongoing
interaction and interventions in patients with congestive heart failure. This chronic illness
requires daily adjustments in self-care, self-monitoring, and self-management
(Francesconi et al., 2019). Changes in care, monitoring, or management may require
alterations in the treatment plan, communication, and interaction with the healthcare
team. The chronic care model allows for daily management and early intervention,
leading to decreased risk for unnecessary hospital readmission.
Definitions of Terms
Though there are many terms in common usage in the DNP project, perhaps
clarification is needed regarding the use of the word project within the context of the
DNP project and the organization’s QI initiatives. The focus of the DNP project is to
develop a CPG as to support the organization’s QI initiative. As QI initiatives are also
called QI projects, I offer this clarification. Although the organization has had a QI
project team that I have been a member of for several months, the DNP project is an
extension of that work, with the development of the CPG.
Relevance to Nursing Practice
Heart failure readmission and patient outcomes impact the patient, as well as
those providing care for this patient population. Research has demonstrated the impact of
CHF and the risk for hospital readmission. Statistics show the number of patients affected
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by this chronic illness is expected to increase over the next 10 years. Although patients
have been identified through the use of predictive tools such as the LACE index too,
practice site readmission rates remain elevated beyond the national average.
As patients are identified by individual risk and through risk stratification, several
factors contribute to unplanned hospital readmission, including system factors of early
discharge from the hospital, lack of symptom management by non-heart failure
specialists during admission, and lack of support services post-discharge. Targeted
interventions such as care coordination and transitional care programs have shown some
improvements in readmission rates; however, the risk for readmission remains. Jun and
Faulkner (2018) noted interventions with the utilization of multi-disciplinary teams
including referral to heart failure specialists and face-to-face communication, have been
demonstrated to reduce the risk for readmission. Nurses also play a significant role in
patient outcomes. Nurses provide continuous care of these complex patients, engage in
medication administration, and provide education on therapies, symptom management,
and self-care. Additional system factors that may contribute to hospital readmission and
patient outcomes is the patient-to-nurse ratio, work environment, and nursing knowledge
of congestive heart failure.
Herrin et al. (2015) conducted an observational study to further understand the
barriers that lead to hospital readmission. Focusing on patient-level barriers such as
health literacy, and social support, noting the specific barriers of living alone,
employment status, and educational level, CHF patients demonstrated an increased risk
for hospital readmission. System barriers noted included access to primary care, as well
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as access to specialty care, and were also associated with lower hospital readmission
rates. Understanding these risks for readmission and the barriers that congestive heart
failure patient’s face allows for implementation of a multi-disciplinary CPG to reduce the
risk for hospital readmission.
There is ample research evidence that supports the development of a practice
guideline focused on coordinating efforts organizationally to assure that patients are
adequately prepared for discharge and have access to resources that can ease the
transition. Prediction of risk for readmission allows healthcare teams to ensure that the
patients’ needs are being assessed and addressed based on their potential risk for
readmission. Identification of comorbidities, common characteristics, evidence of social
support, and individual behaviors play a role in patients’ predictive risk for readmission
(Ritt & Taylor, 2016; Mirkin, Enomoto, Caputo, & Hollenbeak, 2017; Flanagan et al.,
2018).
Building on the potential risk for readmission, healthcare teams must understand
challenges for both patients and the healthcare system. These barriers may lead to
readmission, affect the quality of life for the patient and their family members, and
increase the risk of mortality. The HRRP allows organizations to identify patient
populations that have a higher than expected risk for readmission and implement care
guidelines that reduce this risk and assist patients in overcoming barriers to care.
Reducing patient level and system level barriers allows the patient and their healthcare
team to work toward improved patient outcomes, reducing the need for hospital
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readmission (McIlvennen, Eapen, & Allen, 2015; Ziaeian, & Fonarow, 2016; SevillaCazes et al., 2018; Wood et al., 2019).
Transitioning patients from hospital to home requires the efforts of a multidisciplinary team. This transition includes the timeliness of outpatient follow up,
coordination of care from hospital to home, communication, and self-care. Incorporating
palliative care in this transition, allows for goal setting that is realistic and empowers to
the patient to be an active participant in their care (Donaho et al., 2015; Koser, Ball,
Homa, & Mehta, 2018; Hudali, Robinson, & Bhattarai, 2017). Through an evidencebased CPG, CHF patients are identified, risk stratified, and placed on a heart failure
pathway that allows for increased self-care, reduction in hospital admission, and
improvement in their quality of life.
Local Background and Context
CHF affects more than six million individuals and accounts for more than
700,000 hospitalizations annually (Mirkin, Enomoto, Caputo, and Hollenbeak, 2017).
Many of these patients are readmitted to the hospital within 30-days, with an additional
increase in readmission at 90-days. In 2018, the readmission rate for patients with
congestive heart failure, exceeded the national average of 21.7%. Reducing this
readmission rate below the national average aligns with the mission and goals of the
practice site.
Patients at increased risk are noted to have lower socioeconomic status, be
uninsured, and be greater than 65 years of age. The project setting is a 208-bed facility
within a five-hospital campus system. This system serves an 11-county area with a
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population of more than 3 million individuals. The population served by this facility is
more than 500,000 patients, accounting for more than 100,000 admissions and emergency
room visits annually. This demographic includes predominately non-Hispanic whites,
higher household median income than other regions in the state, the lowest number of
uninsured individuals, and only 16% of the population do not have transportation.
Despite significant efforts over the past six months, the 30-day readmission rate at
the site remains higher than the national average. Strategies including use of the LACE
predictive model and establishing a post-discharge clinic have not been successful to
date. These initiatives have not been well coordinated or implemented across the facility
as they involve varied departments and personnel. Thus, the purpose of the DNP project
is to close the gap in practice, develop a practice-guideline that can potentially pull all of
the disjointed pieces together in a coordinated way, and answer the practice-focused
question: Will a transition of care practice guideline be accepted for full implementation
by an expert panel at this site as a strategy to reduce this 30-day readmission rate in heart
failure patients?
Role of the DNP Student
CHF is one of the most common health concerns that I see in daily practice. As a
cardiovascular advanced practice nurse, working to improve the lives of this patient panel
is a daily endeavor. Patients with CHF deal with the day-to-day self-management of a
disease process that can affect their overall well-being. This ongoing management can
lead to decompensation with small changes in their dietary regimen, missed doses of
medication, or inability to manage symptoms at home.
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The role of the DNP student is to ultimately close a gap in practice through the
DNP project. The site for the project is affiliated with my place of employment; however,
I am not directly employed at this site, minimizing the potential bias for the project.
Implementation of the CPG has the potential to change clinical practice through the
implementation of evidence-based practice, improved communication, and improved
coordination of care. This DNP project has the potential for bridging the gap in nursing
practice leading to a change in culture at the clinical site. These changes lead to decreased
need for hospital readmission, improved coordination of care, improved communication
between the patient and the healthcare team, and empowerment of the patient, leading to
positive social change in caring for patients with chronic congestive heart failure.
Role of the Project Team
Current readmission rates for CHF patients remain above the national average,
despite efforts to coordinate care and transition patients to home. Efforts to reduce the
current 30-day readmission rate have been well-intentioned, but not coordinated. Use of a
CPG bridges the gaps in knowledge to ensure that care is coordinated between healthcare
teams, opens lines of communication, and allows for implementation of guideline-based
therapies.
For the DNP project, and as the DNP project leader, I presented the CPG to an
expert panel derived from the QI team at the site seeking their discussion, feedback and
ultimately, their approval to fully implement. The panel included the heart failure
physicians, heart failure advanced practice providers, members of the quality
improvement team, data analyst, the nursing leadership, cardiac rehabilitation, case
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management, and the cardiology medical director. This team creates a bridge between
hospital leadership and the care teams, working to align national initiatives with network
goals in the care of heart failure patients. The expert panel served a dual purpose, as their
roles as part of this interdisciplinary team include their leadership as well as their care at
the bedside for these complex patients. This team not only impacts the implementation of
care, but also plays a role in the ongoing evaluation of quality metrics, as well as care of
the patient.
Summary
The gap in practice identified is the need for reducing hospital readmission in
patients with CHF. The results of the literature demonstrate that communication and
coordination of care based on evidence and guideline-directed therapies should be used
when working to reduce hospital readmission and improve patient outcomes. Patients
with congestive heart failure are often complex, requiring a multidisciplinary approach to
care. The use of a CPG should be implemented to reduce the risk for hospital
readmission, improve communication and coordination of care, and improve the quality
of life for patients with congestive heart failure. This DNP project will collect and
analyze data, demonstrating the gap in practice and the project site and will be addressed
through the CPG. Section 3 will provide details into the methods used to develop the
CPG, the process of review, and implementation by the key stakeholders identified.
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Section 3: Collection and Analysis of Evidence
Introduction
CHF is one of the leading causes of hospital admission and readmission, affecting
more than a million patients annually. Initiatives from CMS include the enforcement of
penalties to hospitals and healthcare systems with increased 30-day all-cause
readmission. Research at the practice site has demonstrated the use of predictive models,
use of targeted interventions, and coordination of care to reduce the risk for hospital
readmission, yet despite these efforts, the 30- day readmission rate remains elevated
beyond national average (Flanagan et al, 2018; Ritt & Taylor, 2016). Implementation of a
CPG translates evidence into practice to improve the quality of life for patients with
chronic congestive heart failure and has the potential to decrease the influences that
contribute to hospital admission and readmission
CHF is a chronic disease requiring ongoing daily management that leads to
increased risks for hospital readmission. The CMS established the HRRP to reduce
payments to hospitals with increased 30-day readmission rates. Due to this initiative,
healthcare systems have been evaluating methods to identify patients who may be at risk
and implementing interventions that potentially reduce the need for hospital readmission.
This reduction of risk for hospital readmission requires a multifaceted approach. A CPG
involves using predictive risk models to risk-stratify patients, identify patient and system
barriers, and include methods to overcome barriers that patients and healthcare systems
face. The purpose of the DNP project is to bridge the gap in practice evidenced by
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increased readmission rates through a CPG that will more accurately define and
coordinate transition of care processes for CHF patients.
Practice-Focused Question
The practice-focused question is: Will a transition of care practice guideline be
accepted for full implementation by an expert panel at this site as a strategy to reduce this
30-day readmission rate in CHF patients? The gap in practice identified is the need for
reducing hospital readmission, yet with the use of predictive models, transitional care
clinics, and close follow up, readmission rates remain elevated beyond the national
average of 21.7%. The DNP project bridges the gap in practice through a CPG that more
accurately defines the transition of care process for CHF patients, reducing the risk for
hospital readmission.
Sources of Evidence
Published Outcomes and Research
The CPG is based on evidence and involves reducing risks for hospital
readmission. Sources of evidence for the CPG consist of literature that allows for risk
stratification of patients with congestive heart failure at risk for readmission. This CPG
also acknowledges patient and system barriers, allowing for the implementation of
targeted interventions, including the use of palliative care and transitional care clinics to
reduce risks for hospital readmission. The literature review included the database and
search engines CINAHL Plus, Medline, ProQuest. Key search terms included: heart
failure, cardiac failure, CHF, chronic heart failure, congestive heart failure,
readmission, rehospitalization, readmittance, rehospitalization, re-admittance,
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readmission, LACE index, patient barriers, obstacles or challenges, and palliative care.
Limitations of searched articles included full-text articles, published within the last five
years, and conducted in the United States.
Evidence Generated for the Doctoral Project
Participants. Participants who contributed to reviewing the practice-focused
question included a multidisciplinary practice site expert panel. This panel was
comprised of practice site heart failure physicians, and heart failure advanced practice
providers, members of the acute care quality improvement team, an acute care data
analyst, nursing leadership, cardiac rehabilitation, case management, and the cardiology
medical director. This team not only provides care at the bedside, members of this team
guide implementation of the CPG.
Procedures. The development of the CPG was based on evidence. Presentation of
the CPG to the expert panel allowed for input and feedback based on expert opinions of
members. The CPG was presented along with an algorithm for reducing the risk of 30day hospital readmission. Upon a patient’s presentation to the emergency department, the
LACE score is calculated, and diagnostic workup is initiated. If admission is deemed
necessary, patients are admitted to the medicine team with a consult to cardiology. The
current heart failure order set does not include a consult to cardiology. Initiating this care
team early in the process allows for implementation of guideline directed medical therapy
(GMDT) and continuity of care in the ambulatory setting. In patients with new onset
heart failure, further diagnostics with cardiology may be necessary including possible
right and left heart catheterization. Information obtained from this diagnostic testing
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allows for further implementation of guideline-directed medical therapies. Additional
consults to ancillary services that will assist in the assessment of patients as well as case
management/social services, pharmacy, nutrition, cardiac rehab, transitional care nursing,
and palliative care allow for a comprehensive and multidisciplinary approach to assessing
potential risks and barriers to care for these patients. At the time of discharge, the use of a
CHF checklist allows for documentation and data gathering of guideline- directed
therapies and medication reconciliation, as well documentation of the needs assessments
and ambulatory follow up (see Appendix B).
The development of the CPG involved the use of the AGREE II instrument that
assesses for methodological rigor (see Appendix C). This instrument provides a
framework for assessing the quality of the CPG and how information is reported within
the CPG. This tool consists of 23 items in six domains focused on each component of the
CPG. Members of the expert panel completed the tool scoring each domain using the
seven-point scale. A summation of the domain scores are included in the findings and
recommendations (Brouwers et al., 2010). Permissions to use this tool were also obtained
(see Appendix D).
Following presentation of the CPG, members of the expert panel were asked to
complete the AGREE II instrument, and additional input was obtained from the expert
panel using the Delphi technique. These rounds of questions involved information
gathering regarding what solutions would be effective in the guideline, how to monitor
progress following implementation of the CPG, including a timeline for full
implementation, and whether the expert panel agrees with implementation and planning.
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Planning for possible barriers that may hinder implementation include utilization
of resources: Currently there is no inpatient cardiac rehab at each facility, which places
the emphasis of heart failure education on practitioners or nursing. How will we complete
60-minutes of education with a patient? How is the CPG different than what we are
currently doing? Resources are different at each facility; how do we expect to meet the
needs for education? Can low risk patients be managed by the medicine team? How does
the transitional care clinic apply to the clinical guideline? A brief summary of the openended questions used in the qualitative discussion is found in Appendix E.
Protections. The Walden IRB process and manual were followed, as well as the
organizational IRB process in the development and presentation of the CPG to the expert
panel (Manual for clinical practice guideline development, 2019). The site IRB provided
exempt approval number 64183 on February 26, 2020 and Walden University’s IRB
approval was obtained with the approval number 01-16-20-0064183. Members of the
expert panel were asked to participate in the presentation and discussion, and their
anonymity was protected. No incentives were offered for involvement in the process. No
communication with the expert panel was conducted until the completion of the IRB
process for Walden University, as well as the practice site (U.S. Department of Health &
Human Services, 2018).
Analysis and Synthesis
Rating on the AGREE II instrument was summarized using descriptive statistics.
Interrater reliability among the expert panel participants was established using SPSS v26.
In addition to the quantitative summary, qualitative data will be collected to capture the
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discussion and overall support (or lack thereof) for the practice guideline. The Delphi
method allows for communication and feedback (Wilkes, 2015). Using this method
allows for the development of the CPG to reduce the risk for heart failure readmission.
The guideline involves evidence-based practice, feedback from an expert panel, and the
willingness of this group of stakeholders to proceed with full implementation of the CPG.
The Delphi methodology was used in the presentation of the guideline, which includes
the use of open-ended questions and feedback (see Appendix E). As part of the
presentation, the DNP project provided the evidence, rationale, and algorithm to identify
tools to risk stratify patients, obstacles, and barriers for both the patient and the healthcare
system, as well as interventions that allow for the implementation of guideline-directed
therapies that reduce the risk for unnecessary readmissions.
Summary
The DNP project proposed is the development of a CPG to reduce readmission for
patients with congestive heart failure. This project was developed and was presented to
an expert panel of heart failure specialists and stakeholders involved with the care of this
at-risk patient population. The project was presented to the expert panel for review,
discussion, and approval for full implementation at the clinical practice site. Section 4
will provide the results of the DNP project.
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Section 4: Findings and Recommendations
Introduction
The development of a CPG for reducing heart failure readmissions is aimed at
improving the care of patients with heart failure while bridging a gap in nursing practice,
leading to changes in the culture of care at the clinical site. These changes lead to
decreased need for hospital readmission, coordination of care, improved communication
between patients and healthcare teams, and empowerment of patients. In addition, these
changes have the potential to lead to a reduction in hospital admission and readmission,
ultimately decreasing in-hospital mortality and morbidity in patients with chronic CHF.
The purpose of the DNP project was to develop a CPG to reduce heart failure
readmission. This CPG was developed using the LACE risk stratification tool, evidencebased practice guidelines for CHF, heart failure order sets, and transitional care services
designed specifically for patients with CHF. With the reinforcement of the HRRP from
the CMS, reducing heart failure readmissions helps bridge the gap in practice and more
accurately define the transition of care process for CHF patients at the site. This CPG
involves closing the gap in practice through implementation of strategies to reduce 30day readmissions in CHF patients.
Findings and Implications
The DNP project not only demonstrates the potential positive impact for the
organization, but also the positive impact for patients and their families as well as the
healthcare system. Decreasing heart failure readmissions keep patients at home and lower
costs for this patient population. The CPG demonstrates the need for a multidisciplinary
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approach and standardization of processes in caring for patients with CHF (Wood et al.,
2019). While the practice site represents one facility within a five-hospital campus
system, resources vary at each of the five facilities. Using this multidisciplinary team
allows each facility to adapt the CPG to effectively use resources while remaining
fiscally responsible.
The CPG was presented to a panel of nine local experts. These experts
participated in a one-hour overview and discussion of the CPG. Once the presentation
was concluded, the 23-item Agree II survey was sent electronically via SurveyMonkey®
to 9 members of the team. There were nine surveys returned for analysis. The majority of
participants agreed (6) or strongly agreed (7) on all domains except four domains:
stakeholder involvement, rigor of development, applicability, and editorial independence.
One respondent scored these with a response of five which indicates a mild level of
disagreement. One respondent provided no response to domain six.
Data gathered using the Agree II instrument allows for objective evaluation of the
CPG. The score of each respondent allows for determining the quality of the CPG to be
implemented. Scoring of the instrument using a numeric scale, from 1 (strongly disagree)
to 7 (strongly agree). The average score of each domain is outlined in Table 1.
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Table 1
Summary Scores on AGREE II Survey Domains and Selected Questions
Scope and Purpose
Stakeholder Involvement
5. The views and preferences of the target population (patients, public, etc.) have
been sought.
Rigor of Development
8. The criteria for selecting the evidence are clearly described.
13. The guideline has been externally reviewed by experts prior to its publication.
14. A procedure for updating the guideline is provided.
Clarity of Presentation
Applicability
20. The potential resource implications of applying the recommendations have been
considered.
21. The guideline presents monitoring and/or auditing criteria.
Editorial Independence
22. The views of the funding body have not influenced the content of the guideline.
23. Competing interests of guideline development group members have been
recorded and addressed.

Average
Score
6.81
6.51
5.8
6.33
5.8
6.1
5.5
6.70
6.47
6.4
6.3
5.91
5.8
6

The Delphi method with the expert panel addressed the practice-focused question:
Will a transition of care practice guideline be accepted for full implementation by an
expert panel at this site as a strategy to reduce this 30-day readmission rate in CHF
patients? The expert panel members were asked six open-ended questions pertaining to
the CPG (see Appendix E). Discussion of these questions included current processes,
implications regarding heart failure readmission, and how the GPG reflects use of
guideline-directed therapy.
After review of the CPG, the expert panel discussion included the need for
detailed information regarding criteria for admission and ischemic workup (including
stress testing, echocardiography, or cardiac catheterization) at the discretion of the
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consulting cardiologist. Low acuity patients will continue to be followed in the
ambulatory setting by the primary care physician. If the need arises, an ambulatory
consult to cardiology may be placed. These changes to the CPG are supported by directed
therapies of the American College of Cardiology (ACC) and the American Heart
Association (AHA) guidelines for managing heart failure (Yancy et al., 2017, American
Heart Association, 2017). The discussion reflected incorporating evidence-based practice,
improving the culture of care, and methods on reducing 30-day hospital readmissions.
The expert panel engaged in a robust discussion regarding the CPG. For the most
part, the discussion was very positive. One member of the panel stated, “sounds like the
CPG will help us to reduce readmissions for heart failure patients”. Another member of
the expert panel stated, “I think it will work.” However, there was also some debate that
ultimately required some refinements to the CPG. For example, there was discussion
about the need for defined criteria demonstrating the need for hospital admission when
patients present to the emergency department. These criteria were defined as elevation of
ProBNP, evidence of pulmonary edema on chest x-ray, LACE score of greater than 5,
elevated troponin, and physical exam evidence of volume overload. These criteria
demonstrate patients’ needs for more aggressive therapies than what could be provided in
the emergency department. Revisions to CPG reflect recommendations of the expert
panel (see Appendix F).
Additional debate ensued regarding the need for an automatic consult to
cardiology for patients admitted with a diagnosis of CHF. Referral to the specialty care of
cardiology allows for implementation of guideline-directed therapies, interventions, and
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coordination of care at discharge. In addition, this patient population often needs an
ischemic workup that may include stress testing, echocardiography, and coronary
angiography. Workup may be completed during current hospitalization or deferred to the
ambulatory setting to allow for recovery from acute illnesses. Involving cardiology at
admission allows for early intervention, implementation of evidence-based therapies, and
use of a multidisciplinary team of providers to care for patients while hospitalized, as
well as in the ambulatory setting. Potential concerns involve coordinating care with
primary care providers, as some of these providers are not affiliated with the network.
This creates obstacles with obtaining ambulatory data to determine if patients are
following up as outlined in the CPG, as well as continuing with GMDT as prescribed
prior to discharge.
Additional discussion with the expert panel included agreement across the board
that the use of the multidisciplinary approach to care would be effective; however, with
financial constraints and variability of resources in facilities, implementation of the CPG
should be phased in over a 3-month period of time. The initial phase of implementation
includes education and awareness of the practice guideline for providers (physician and
APP) in the emergency department, hospitalists, and the cardiology department.
Additional teams included in the implementation of the CPG include case management,
pharmacy, nursing (including transitional care nursing), clinical informatics, and cardiac
rehabilitation. Communication includes changes in workflow that are organization and
provider-focused, education materials, current guidelines, and protocols for
implementation. Additional phases of implementation include communication of
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processes while the patient is hospitalized, use of the multidisciplinary team, further
engagement of staff, and use of detailed protocols implemented into the EHR.
Recommendations
The nine-member expert panel unanimously recommended full implementation of
the CPG. As part of this recommendation, a modified for phased implementation plan
should occur over a three-month period, with education, data collection, and evaluation.
The initial one-month phase includes education for providers in primary care, emergency
department, cardiology providers, and hospitalists. Education will also occur with
nursing, cardiac rehabilitation, case management, transitional care nursing, pharmacy,
and the QI team, which also includes data analysts. Education for these departments
includes presentation of current hospital readmission rates, practice site goals for hospital
readmission, heart failure guidelines, and the CPG.
In phase two of implementation, data collection included 50 patients presenting to
the emergency department with a primary diagnosis of congestive heart failure. Criteria
have been outlined in the CPG to assist providers with determining if hospital admission
is recommended or aggressive diuresis is needed while the patient is in the emergency
room. Prior to discharge from the emergency department, criteria determine the pathway
for ambulatory follow up for patients based on their LACE score.
The next phase of implementation a multidisciplinary team will be involved in
with CHF patients who are admitted acute exacerbation of heart failure. At the time of
admission and initiation of the CPG, a consult is placed to cardiology. In patients with
new onset heart failure or acute on chronic heart failure with a change in the documented
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ejection fraction (EF), the cardiologist will determine the treatment plan including
ischemic workup and implementation of guideline directed therapy. As guideline directed
medical therapy is initiated, the multidisciplinary team will be consulted for care
coordination and optimization of treatment. In patients with an EF< 30%, a consult to
electrophysiology and heart failure physicians will also be placed. Consultation with
these subspecialties is initiated for ongoing follow up in the ambulatory setting.
Strengths and Limitations of the Project
Strength of the DNP project included the development of a CPG that can be used
across disciplines. This guideline demonstrates the use of a multidisciplinary team to
identify patients that are at increased risk for readmission, criteria for patients that require
hospital admission, use of the multidisciplinary team, and demonstration of guideline
directed therapies. The algorithm for the CPG provides detailed steps for each phase of
care, including hospitalization and transition to home. This project uses the Agree II
instrument for the assessment of methodological rigor.
Limitations of the DNP project focused on inclusion of cardiology in the
management of congestive heart failure patients, however education of the
multidisciplinary team is needed for effective use of the CPG. This project will not
demonstrate the impact on 30-day hospital readmission until further evaluation following
the implementation of the practice guideline. Tracking and effectiveness through data
collection is imperative for continued improvement in care of this patient population.
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Summary
Collaboration, communication, engagement of staff, and effective use of
resources allows for implementation of evidence-based practice. As a multidisciplinary
team, the CPG provides guidance in caring for patients with CHF. This guideline
promotes positive social change by improving patient outcomes, decreasing mortality and
morbidity, while decreasing heart failure readmissions. The differentiation in the CPG to
reflect ischemic workup allows for broad work up to include, but not limited to stress
testing and cardiac catheterization. Additional recommendations of the expert panel
included implementation of tailored therapies for each patient. Identification of potential
barriers allows for directing care and effective use of resources based on each facility.
Coordination of care by consulting cardiology allows for building relationships and
implementing care that may previously been delayed. Additional effective therapies
include the use of pharmacy staff to verify and reconcile medications, as well as assist
with education of medication therapies. Inclusion of case management allows for early
identification of social barriers that may influence care after discharge, such as
transportation, support, and ability to afford care/medications.
Through implementation of the guideline, data collection will include evaluation
of the LACE score, which demonstrates a decreasing risk for hospital admission.
Additional data collection includes long-term evaluation of the CPG to determine if a
decrease in hospital readmission is occurring. Decreasing the LACE score is reflective of
decreasing hospital readmissions. As part of the CPG, long-term evaluation will occur for
6-months to determine the correlation of the CPG and reduction of heart failure
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readmissions. The practice site will be responsible for ongoing evaluation and updating
of the CPG reflecting changes or updates in GMDT.
Education across disciplines of the CPG allows for care coordination.
Consultation to cardiology at time of admission decreases the need for nursing staff to
ask for specialty consultation for the care of CHF patients. Implementation of the CPG
for all CHF patients decreases potential conflict regarding care coordination. Current
processes include consultation to cardiology; however, the order may not be placed,
creating a delay in care.
Education provided for patients may vary depending on discipline providing
education. Resources vary per facility and may not include inpatient cardiac
rehabilitation. To overcome this barrier, educational materials for patients should be
standardized. Providing and documenting standardized education prior to discharge
allows for evaluation of the effectiveness of teaching.
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Section 5: Dissemination Plan
CHF is a leading cause of morbidity and mortality, leading to hospital admission
and readmission. Each of these readmissions creates a financial burden for hospitals as
well as patients, leading to expenditures of greater than $10,000 per readmission (Bailey
et al., 2019). With readmission rates that currently exceed the national average of 21.7%,
the CPG provides awareness of current issues, strategies for overcoming barriers, and
recommendations for communication, follow up, and access to care.
Dissemination of this project includes a detailed presentation to the
multidisciplinary team involved in the care of this patient population across a fivehospital campus system. This team includes hospitalist and emergency department
physicians and APPs, case management, nursing (bedside and transitional care), cardiac
rehabilitation (inpatient and ambulatory), heart failure physicians and APPs, general
cardiology physicians and APPs, clinical informatics, and the quality improvement team.
Further dissemination of this DNP project includes presentation of the CPG to
membership of the Heart Failure Society of America (HFSA) and American Association
of Heart Failure Nurses (AAHFN) as well as presenting during the practice site
cardiology annual symposium. Presentation of this project builds on DNP essentials as
outlined by the American Association of Colleges of Nursing (AACN). These essentials
address foundational components of advanced practice nursing, focusing on assessment,
evaluation, collaboration, and the implementation of new care delivery models for target
populations. These models of care influence organization, political, and economic
perspectives of care (AACN, 2016).
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Analysis of Self
As a scholarly practitioner, the DNP process allows for professional and personal
growth. Not only did this project allow me to expand my knowledge of CHF, it also
afforded the opportunity to research literature on CHF, exam care processes,
communication, and interactions with patients. As I gained a deeper understanding of this
patient population, I also gained an enhanced understanding of the social determinants
that affect patients daily. This awareness allows for working to improve care processes,
but also promote evidence-based practice for patients. Guidelines direct care: however,
we may not be able to meet these guidelines due to cost, patient literacy, access to care,
or social support. Care providers must be innovative in terms of ways to care for patients
while improving their quality of life.
In addition to learning and growth as a scholarly practitioner, I was able to
develop relationships of care with a multidisciplinary team. This team approach allows
for promoting engagement in patient care and promotes effective transitions for our
patients from hospital to home. This project has opened lines of communication and
engagement of a multidisciplinary team, creating an awareness for the need to change the
culture of care for CHF patients.
As a clinician, the DNP process allows for developing clinical knowledge and
implementation of clinical guidelines based on evidence into daily practice. These
guidelines demonstrate therapies designed to improve patient outcomes and mortality.
Managing CHF patients presents complex challenges, as these patients often present
multiple comorbid conditions. Management of these multiple health conditions is
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accomplished through education, daily management of therapies, detection of symptoms,
and early intervention, ultimately decreasing the need for hospitalization. As a manager
of the DNP project, this process allows practitioners to seek out ways to improve care of
designated patient populations. Working to create new processes of care, demonstration
of leadership through collaboration, critical analysis of research and evidence, and
offering new care processes allows for advancing the nursing profession. The
foundational components of the DNP focus on demonstrating transformational change in
nursing.
Summary
This DNP project includes the development and implementation of a CPG to
reduce 30-day CHF readmissions. The CPG was developed and presented to an expert
panel at the practice site seeking their feedback and ultimately approval for full
implementation of the CPG. The panel was comprised of CHF physicians, CHF APPs,
members of the quality improvement team, data analysts, nursing leadership, cardiac
rehabilitation, case management, and the cardiology medical director. This team not only
provides care at the bedside, but also care directly related to the implementation of the
CPG. This guideline was presented and approved for full implementation at the practice
site.
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Appendix C: Agree II
Domain 1. Scope and Purpose
1. The overall objective(s) of the guideline is (are) specifically described.
2. The health question(s) covered by the guideline is (are) specifically described.
3. The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described.
Domain 2. Stakeholder Involvement
4. The guideline development group includes individuals from all relevant professional
groups.
5. The views and preferences of the target population (patients, public, etc.) have been
sought.
6. The target users of the guideline are clearly defined.
Domain 3. Rigour of Development
7. Systematic methods were used to search for evidence.
8. The criteria for selecting the evidence are clearly described.
9. The strength and limitations of the body of evidence are clearly described.
10. The methods for formulating the recommendations are clearly described.
11. The health benefits, side effects, and risks have been considered in formulating the
recommendations.
12. There is an explicit link between the recommendations and the supporting evidence.
13. The guideline has been externally reviewed by experts prior to its publication.
14. A procedure for updating the guideline is provided.
Domain 4. Clarity of Presentation
15. The recommendations are specific and unambiguous
16. The different options for management of the condition or health issue are clearly
presented.
17. Key recommendations are easily identifiable.
Domain 5. Applicability
18. The guideline describes facilitators and barriers to its application.
19. The guideline provides advice and/or tools on how the recommendations can be put into
practice.
20. The potential resource implications of applying the recommendations have been
considered.
21. The guideline presents monitoring and/or auditing criteria.
Domain 6. Editorial Independence
22. The views of the funding body have not influenced the content of the guideline.
23. Competing interests of guideline development group members have been recorded and
addressed.
Overall Guideline Assessment
Items are measured on a scale of 1 to 7; 1 indicates strong disagreement, 7 equates to strong
agreement. Permission to use and reprint from Brouwers et al. (2010) has been obtained.
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Appendix E: Questions Delphi Method
1. What do you anticipate will be effective or ineffective in the guideline once
implemented?
2. How might we monitor progress following implementation of the clinical practice
guideline?
3. What is the timeline for full implementation?
4 Resources are different at each facility, how could we overcome these differences?
5. What organizational and patient barriers may hinder implementation?
6. Do you (as the expert panel) agree with implementation of the clinical practice
guideline?
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Appendix F: CPG (Revised)

Represents changes to reflect criteria for admission: elevated ProBNP, elevated troponin, abnormal EKG, CXR –
demonstrating pulmonary edema, physical exam demonstrates acute exacerbation of CHF
Represents changes to reflect ischemic workup: cardiac catheterization changed per expert panel
recommendation to reflect ischemic workup

